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Transcapillary colloid osmotic gradient and body fluid volumes In renal
failure. The aim was to study the transcapillary fluid balance in dialysis
patients during and after ultrafiltration. Plasma and subcutaneous
interstitial fluid (wick technique) colloid osmotic pressure, plasma
volume (I'25-albumin space) and extracellular fluid volume (radiosulfate
space) were measured in nine patients on maintenance hemodialysis
before (pre-dialysis state) and after (dry-weight state) ultraffitration. In
the pre-dialysis state, interstitial colloid osmotic pressure was reduced
compared to normal controls (12.7 3.5 versus 15.8 2.7 mmHg,
mean values SD) and transcapillary colloid osmotic gradient increased
(15.3 3.0 versus 12.8 2.7 mmHg). Ultrafiltration resulted in a
parallel decrease of plasma volume and interstitial fluid volume of 19 to
20%, and an increase in mean interstitial colloid osmotic pressure of 3.4
mmHg and in mean transcapillary colloid osmotic gradient of 1.9
mmHg. The mean ultrafiltration rate was 21.9 1.9 mllmin and the
plasma refilling rate was 16.5 2.7 mI/mm. It is concluded that the
changes in plasma and interstitial fluid colloid osmotic pressure tend to
preserve plasma volume and limit the interdialytic increase in intersti-
tial fluid volume.
Patients with chronic renal failure on maintenance
hemodialysis commonly show abnormalities in body fluid com-
position [1—5]. In addition to increases in extracellular fluid
volume, alterations in the partition of volumes between the
intravascular and the interstitial spaces are reported in chronic
renal failure [1, 2, 5]. Intermittent fluid overload and the need
for fluid withdrawal during dialysis frequently create clinical
complications [6—8]. Plasma volume depletion is an important
factor in the pathogenesis of symptomatic hypotension which
occurs in approximately 25% of hemodialysis treatments [6—11].
With the tendency to at least intermittent fluid overload,
activation of local edema—preventing factors [12], such as
reduced interstitial colloid osmotic pressure, could be expected
in dialysis patients. Hildebrandt et al [13] recently found
evidence for reduced extravascular albumin mass in patients on
chronic hemodialysis. Reduced subcutaneous interstitial colloid
osmotic pressure has been found in patients with fluid overload
due to nephrotic syndrome, heart failure and hepatic cirrhosis
[14—16].
Dry weight or ideal weight for a given dialysis patient is
defined as the weight obtained at the end of hemodialysis
treatment, below which the patient often will suffer sympto-
matic hypotension [6, 7].
The aim of the study was to examine to what extent the
edema—preventing mechanisms of reduced interstitial colloid
osmotic pressure and increased transcapillary colloid osmotic
gradient are activated in patients with chronic renal failure on
maintenance hemodialysis. A secondary aim was to study the
changes in plasma colloid osmotic pressure and plasma volume
during ultrafiltration. In order to accomplish these objectives,
colloid osmotic pressure in plasma and interstitial fluid and
body fluid volumes (plasma volume and extracellular fluid
volume) were measured in a pre-dialysis fluid state and after
ultrafiltration to a dry-weight state. In addition, plasma colloid
osmotic pressure was followed during ultrafiltration.
Material
Patients Nine patients (2 females and 7 males, mean age 65.6
years, range of 61 to 70 years old) with chronic renal failure
were studied. Patient 1 was anephric and the other patients had
creatinine clearance less than 5 mI/mm. Diagnosis and clinical
information are given in Table 1. The body weight and the
laboratory values in Table 1 are data from day 1 (before
treatment). Patient 2 had moderate edema in the ankle region on
day 1, the other patients did not have edema. None of the
patients had congestive heart failure, nephrotic syndrome,
diabetes mellitus or liver disease. They were all established on
hemodialysis treatment for at least eight weeks and were
investigated as outpatients. Six of the patients were treated with
furosemide (mean dosage 590 mg/day, range 160 to 1000
mg/day) and four patients were on antihypertensive treatment
(Table 1). All medication was continued in unchanged dosage
during the investigation.
Normal subjects Colloid osmotic pressure in plasma and
interstitial fluid were measured in 16 normal subjects (four
females and 12 males, mean ageS! years, range of 33 to 72 years
old) [14]. Plasma and extracellular fluid volume were measured
in another group of 19 normal subjects (11 females and eight
males) aged 22 to 54 years (mean 36 years) [14].
Informed consent was obtained in each case. The protocol
was approved by the Ethical Committee, Norwegian Council
for Science and the Humanities.
Methods
Design of the study Plasma and extracellular fluid volume
were measured in the morning under fasting condition and in
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Table 1. Clinical and laboratory data of the patientsa.
Body Body Serum Serum Serum Duration of Antihypertensive
Patient Clinical Age height weight MAP Hct urea creatinine albumine dialysis diuretic
no, diagnosis (years) Sex (cm) (kg) (mmHg) (%) (mmolell) (Mmolell) (gil) (months) treatment
I TBC 62 M 173 70.5 120 25 22.4 1149 33 12 none
2 CON 70 M 162 76.4 107 31 26.1 415 31 5 F+ A
3 NSC 61 M 178 75.0 110 28 24.0 1060 32 6 F+ A
4 CON 63 F 157 51.0 117 28 23.0 884 41 25 F+ A+ C
5 CON 67 M 178 65.8 95 27 36.8 946 36 41 none
6 CGN 69 M 176 82.0 105 24 33.0 955 38 4 F
7 CON 67 F 169 59.5 125 22 23.7 1061 31 4 C
8 PCK 61 M 170 62.4 107 25 26.1 1140 36 17 F
9 CPN 70 M 163 60.9 103 30 29.7 990 37 31 F
a Abbreviations are: TBC, renal tuberculosis; CON, chronic glomerulonephritis; NSC, nephrosclerosis; PCK, polycystic kidney disease; CPN,
chronic pyelonephritis; MAP, mean arterial blood pressure; F, furosemide; A, aipha-methyldopa; C, captopril.
the supine position. All subjects were recumbent for at least 30
mm before the injections were given. The measurements of
plasma and interstitial colloid osmotic pressure were performed
in patients and normal subjects in the supine position and at the
same time of the day. Both patients and normal subjects were
ambulatory until the blood test for plasma colloid osmotic
pressure was drawn.
In the patients, body fluid volumes and colloid osmotic
pressure in plasma and subcutaneous interstitial fluid were
measured on day 1 in pre-dialysis state (48 to 72 hours after
hemodialysis). On days 2 and 3, ultrafiltration was performed in
order to bring the patient as near to dry-weight as possible, and
was followed by hemodialysis without transmembrane pressure
for two hours. Plasma colloid osmotic pressure was measured
before, during and after ultrafiltration. The measurements per-
formed on day 1 were then repeated on day 4 in exactly the
same manner.
Ultrafiltration procedure Ultrafiltration treatment was per-
formed using a Oambro AK-b proportioning system with a
Oambro-Lundia plate filter (11.5 t) (Oambro Industries, Bar-
rington, Illinois, USA). Ultrafiltrate was collected during treat-
ment and the volume measured. Infusions were not given
during ultrafiltration. Blood samples were collected from the
arterial blood line at the start, and after 30, 60, and 120 mm, and
at end of ultrafiltration for measurements of plasma colloid
osmotic pressure and hematocrit.
Colloid osmotic pressure A colloid osmometer (Department
ofPhysiology, University of Bergen, Norway) made for 5 gliter
samples with Amieon PM3O membranes was used [17]. The
coefficient of variation within assays was 4.3% (N = 12) and
between assays 4.9% (N = 10).
Interstitial colloid osmotic pressure Subcutaneous interstitial
fluid was collected by the wick technique [18—20], Under
aseptic conditions four double nylon wicks (containing 600
filaments, diameter 1 mm) soaked in saline were sewn into
subcutaneous tissue on the side of the thorax in a length of 5 to
8 cm. The skin was anaesthetized by intradermal injections of
0.1 to 0.2 ml of lidoeaine (20 mglml) at the sites of the entrance
and exit of the wicks. Straight (75 mm long) needles without
cutting edges were used for implantation (Acufirm, Dreieich,
Federal Republic of Germany). After one hour implantation the
wicks were removed and transferred immediately to a tube
containing mineral oil. Only unstained or slightly pink wicks
were accepted, red wicks being excluded. Wick fluid was
isolated by centrifugation under mineral oil [19] and colloid
osmotic pressure was measured by the osmometer mentioned
earlier. All the interstitial fluid pressure values represent the
mean of at least two (two to four) separate measurements of
wick fluid from two to four wicks.
Plasma volume Plasma volume (PV) was determined as the
initial '251-albumin distribution space as previously described
[14]. Values are given as ml per kg lean body mass (mllkg
LBM).
Blood volume (BV) BV was calculated from PV and hemato-
crit using a Fcell ratio (ratio of whole body hematocrit to large
vessel hematocrit) of 84% in normal subjects and 81% in the
dialysis patients [11. Values are given as ml per kg lean body
mass (mllkg LBM).
Extracellular fluid volume Extracellular fluid volume was
measured by intravenous administration of radiosulfate as
previously described [14]. Values are given as ml per kg lean
body mass (mllkg LBM).
Interstitial fluid volume Interstitial fluid volume equals extra-
cellular fluid volume minus plasma volume and the values are
given as ml per kg lean body mass (mllkg LBM).
Lean body mass LBM was calculated from body height and
weight using the formulas given by Womersley et al [21].
Plasma refilling rate (PRR) PRR represent a measure of the
fluid volume transport from the interstitium to the intravascular
space during ultrafiltration and the values are given as mllmin.
PRR was calculated using the following equation:
PRR = (UF-volume — PV)IUF-time
where UF-volume is ultrafiltrate volume in ml, PV is the
calculated change in plasma volume during ultrafiltration in ml,
and UF-time is the duration of ultrafiltration in mm. APV was
calculated as:
APV PVb — PVa
where PVb is plasma volume before ultrafiltration and PVa
plasma volume after ultrafiltration. Plasma volume measured on
day 1 was used as PVb on day 2, and the mean value of plasma
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Table 2. Colloid osmotic pressures and body fluid volumes.
subjects
Patients with renal failurea
Normal Pre-dialysis state Dry-weight state
Plasma colloid osmotic pressure (mmHg) 28.6 3.4 28.0 4.2 33.3 55**
Interstitial colloid osmotic pressure (mmHg) 15.8 2.7 12.7 3,5* 16.1 3,9**
Transcapillary colloid osmotic gradient (mmHg) 12.8 2.7 15.3 3.0* 17.2 4.1*
Lean body mass (LBM) (kg) 51.3 8.3 52.5 6.8 51.3 6.6
Plasma volume (ml kg' LBM) 58.3 5.2 73.0 10,6** 59.7 11.6
Blood volume (ml kg-I LBM) 82.7 6.5 93.0 15.1 78.5 14.7**
Interstitial fluid volume (ml kg LBM) 166.1 20.1 220.0 54,9* 178.0 43,3**
Ratio of blood volume to interstitial fluid volume 0.51 0.08 0.44 0.09* 0,45 0.06
Values in pre-dialysis state are values from day 1 and dry-weight state from day 4. * P < 0.05, ** P < 0.01 (comparisons between values in
pre-dialysis state and normal subjects, and between values in dry-weight and in pre-dialysis state). Results are expressed as mean values SD.
volume measured on day 1 and 4 was used as PVb on day 3. PVa
was calculated using the following equation:
PYa = X Cb/Ca
where Cb is the albumin concentration equivalent to III, (plasma
colloid osmotic pressure) before ultrafiltration and Ca is the
value corresponding to III, after ultrafiltration. The albumin
concentration equivalent to III, was calculated using Landis and
Pappenheimer's relation [22, 23]. As a control, the changes in
plasma volume were also calculated from the changes in hem-
atocrit during ultrafiltration using Beaumont's formula [24].
Statistical methods Wilcoxon's test for two independent
samples and Wilcoxon's test for paired observations were used.
Correlations were calculated by least square linear regression
analysis. Results are expressed as mean SD.
Ultrafiltrate volume (ml) 2657 783 (1100—4200)
Ultrafiltration rate (mI/mm) 21.9 1.9 (19.4—25.4)
Plasma refilling rate (mL'min) 16.5 2.7 (11.2—20.7)
Change in plasma colloid osmotic
pressure (mmHg) 9.9 4.6 (4.5—19.0)
Change in body weight (kg)" 3.0 1.3 (1.4—5.9)
Body fluid volumes
While plasma volume (PV) was increased in patients on day
1 compared to normal subjects, blood volume (BV) was not
significantly increased (Table 2). Both PV and BY decreased
significantly from day 1 to 4 and the values on day 4 were not
different from normal subjects (Table 2). Interstitial fluid vol-
ume (IFY) was increased on day 1 compared to normal sub-
jects, and IFY had decreased significantly on day 4 (Table 2).
IFY on day 4 was not significantly different from normal
subjects. Excluding patient 2 (vide infra) BY on day 4 was
significantly reduced compared with normal subjects (P < 0.05)
while IFY on day 1 in this group was increased (P < 0.05). The
ratio of BY to IFY in the patients was reduced compared to
normal subjects and did not change after ultrafiltration (Table
2). The mean decrease in extracellular fluid volume (ECY) from
Colloid osmotic pressures. mmHg
xx *
Table 3. Ultrafiltration dataa
x
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a Values expressed as mean SD and range, N = 18.
b Change in body weight from day 1 (pre-dialysis state) to day 4r = 0.61 (dry-weight state).P< 0.05
Results
r = 0.71 Colloid osmotic pressures
P < 0.05 Plasma colloid osmotic pressure (II) in the patients on day 1
was not different from that of normal subjects (Table 2) and it
increased significantly from day ito day 4. On day 1 interstitial
fluid colloid osmotic pressure (IIi) was decreased by approxi-
mately 3 mmHg compared to normal subjects (Table 2) and II
i i u i j u i i u ; i increased significantly from day 1 to day 4. In patients on day 4
14 18 22 26 30 34 II was not significantly different from normal subjects. The
Plasma transcapilarycolloid osmotic gradient (iI — III) in patients was
Fig. 1. Colloid osmotic pressure in plasma and in subcutaneous increased by approximately 2.5 mmHg compared to normal
interstitialfluid in patients with renal failure (pre-dialysis state) (5) with subjects, and III, — II, increased further after ultrafiltrationlinear regression line (full drawn line) and in normal subjects (x) with (Table 2). Significant correlations were found between III, and
linear regression line (broken line). II both in patients on day 1 and in normal subjects (Fig. 1). III,
increased approximately 10 mmHg during ultrafiltration (Table
3) and most of the increase came during the first hour of
ultrafiltration (Figure 2).
898 Fauchald
:2'
&
&
46 -
42 -
36 -
34 -
30 -
26 -
Plasma colloid osmotic pressure during
ultrafiltration
0 30 60 90 120
Time, minutes
Fig. 2. Plasma colloid osmotic pressure during ultrafiltration (N = 18)
(mean values with indication of SD).
day ito 4 was 3181 ml (19.9%; range 11 to 39%), mean decrease
in IFV was 2384 ml (19.4%; range 7 to 43%) and the mean
decrease in PV was 797 ml (19.9%; range 6 to 37%). There was
a negative correlation (r = 0.74, P < 0,05) between the change
in PV expressed as reduction in PV in percent of reduction in
ECV from day ito 4 and IFV on day 1.
No correlation between II and JFV was found on day 1 or
day 4.
The changes in PV from day 1 to day 4 were correlated to
changes in albumin concentrations equivalent to III,, calculated
from Landis and Pappenheimer's relation [22], (r 0.67, 0.01 <
P < 0.05) and the changes in IFV from day 1 to day 4 were
correlated to the changes in albumin concentrations equivalent
to H, (r = 0.72, 0.01 <P C 0.05).
Ultrafiltration treatment
The difference between mean ultrafiltration rate and mean
plasma refilling rate (PRR) was 5.4 1.7 mllmin (Table 3).
There was no difference in PRR on days 2 and 3 (17.2 2.7 and
15.7 2.7 ml/min respectively). The change in body weight
from days 1 to 4 correlated well with change in ECV (r =0.87,
P C 0.01). All patients except patient 2 and 5 had a blood
pressure drop (decrease in systolic blood pressure of more than
40 mmHg or systolic blood pressure less than 100 mmHg)
during the last part of ultrafiltration on day 3. Patient 2 still had
slight edema in the ankle region on day 4 and was clinically not
in dry-weight, while patient 5 was without edema both on day 1
and 4 and clinically judged in dry-weight. All blood pressure
drops were transient and were treated by temporary reduction
in ultrafiltration rate or termination of ultrafiltration and eleva-
tion of the legs. No other complications during or after treat-
ment were recorded.
In 13 of the ultrafiltration sessions, the changes in PV
calculated from changes in III, and from changes in hematocrit
were compared. Mean reduction in PV calculated from III, was
641 151 ml and from hematocrit was 575 192 ml, and the
correlation between the values was significant (r = 0.80, P C
0.01).
Discussion
Activation of local edema—preventing mechanisms, such as
reduced interstitial fluid colloid osmotic pressure (IIJ, have
been described both in experimental animals [25—27] and in
patients with fluid retention due to heart failure [15), nephrotic
syndrome [14] and hepatic cirrhosis [16]. The mechanism for
reduction in II is thought to be both dilution and lymphatic
wash—out of interstitial proteins [12, 25). From studies in
experimental animals [25, 26, 28] and in patients with nephrotic
syndrome [29] and heart failure [15], it is apparent that a
reduction in II is quantitatively more important than an in-
crease in interstitial hydrostatic pressure as an edema—prevent-
ing mechanism. Measurements of subcutaneous II by the wick
method give reproducible results and can be used with a
minimum of discomfort for the patients [20]. To what extent
wick fluid measurements reflects colloid osmotic pressure in the
interstitium has been thoroughly investigated and discussed in
earlier works of Fadnes and Aukland [30], Noddeland [20], and
Aukland and Nicolaysen [25]. The values of II measured by the
wick technique are relatively high with values in normal sub-
jects subcutaneously at the thorax of 15 to 16 mmHg and at the
ankle region 10 to 12 mmllg [14, 20, 31]. However, direct
measurements of !I by an implantable colloid osmometer [32]
and by sampling of interstitial fluid by the wick—catheter
method [32] or by blister technique [33] give II values of the
same magnitude as the wick technique. The high values of II
are also supported by estimates of interstitial protein content in
skin and skeletal muscle based on protein content in excised
tissues and lymph [25, 34].
Radiosulfate space has been extensively used as a measure of
extracellular fluid volume (ECV) in patients on maintenance
hemodialysis [1—5, 35, 36], and close correlations have been
found between change in radiosulfate space and change in body
weight during dialysis or ultrafiltrate volume [1, 3, 4].
The control group for colloid osmotic pressures being nearly
15 years younger, was not well matched to the patients.
However, age did not seem to influence the values for subcu-
taneous interstitial pressure much as Noddeland [201, who in a
younger group of normal subjects (mean age 22 years) and by
using the same method, found values for III, and II of the same
magnitude as in the present older (mean age 51 years) group of
normal subjects (H 26.9 4.1 and 28.6 3.4 mmHg respec-
tively and II 15.8 2.3 and 15.8 2.7 mmHg respectively).
The control group for body fluid volumes was also younger than
the patients and not well matched regarding sex. Relating the
body fluid measurements to lean body mass minimized the
influence of the age and sex difference on the results.
Measurements of subcutaneous II and transcapillary colloid
osmotic gradient (Ii — IIi) in renal failure have not been
reported earlier. In the pre-dialysis state mean II was reduced
by approximately 3 mmHg and III, — II, increased by 2.5 mmHg
compared to normal subjects. The values for body fluid vol-
umes confirm the tendency to fluid retention in pre-dialysis
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state [1—5]. Except patient 2 all patients in the present study
were considered to be at or near dry-weight on day 4, as
confirmed by the values for interstitial fluid volume (IFV). The
increase in II in dry-weight state (day 4), was of a magnitude
which could be estimated from the decrease in IFV, assuming
unchanged interstitial protein mass from day ito 4 using Landis
and Pappenheimer's relation [22] between colloid osmotic pres-
sure and protein concentration. Due to the same relation, the
parallel decrease of 19 to 20% in plasma volume (PV) and IFY
from day I to 4 should result in a greater increase in III, than in
III, and this was confirmed by the measurements in Table 2. The
correlation between the changes in body fluid volumes and in
albumin concentrations equivalent to III, and II also suggested
that the changes in colloid osmotic pressures from a pre-dialysis
to dry-weight state is mainly volume dependent. Estimates of
subcutaneous interstitial protein mass based on protein concen-
trations calculated from II by Landis and Pannenheimer's
relation [221 and from the values for IFV indicated approxi-
mately equal values in normal subjects and in the patients. This
should mean that the reduction in II in the pre-dialysis state
was due to dilution. The estimates were based on an equal
distribution of subcutaneous and non-subcutaneous IFV in
normal subjects and patients. The reduction in extravascular
protein mass in hemodialysis patients found by Hildebrandt et
al [13] did not seem to be reflected in the subcutaneous
interstitial fluid.
Hypovolemia is an important factor leading to symptomatic
hypotension during hemodialysis [6, 7, 9—11, 37]. During iso-
lated ultrafiltration the increase in III, is the main force recruit-
ing fluid from the extravascular space [37, 38]. In the present
study only the mean PRR during ultrafiltration was calculated.
PRR was probably low during the first part of ultrafiltration until
a reduction in PV lead to an increase in Iii,, and resulted in a
PRR near the same magnitude as the ultrafiltration rate (UFR).
With the present UFR, most of the increase in III, occurred
during the first hour, and PRR approached UFR after two hours
of ultrafiltration (Fig. 2). The value of PRR was close to that
reported by Rouby et a! [37] during isolated ultrafiltration (17.2
mllmin) and was somewhat higher than values found during
hemodialysis and ultrafiltration [10, 11]. Koomans et al [39]
recently reported that PRR was related to the degree of tissue
hydration, and the change in interstitial tissue compliance from
high values in overhydration to low values in normo— and
dehydration was in accordance with experimental evidence [40,
41]. The present finding of a negative correlation between the
percentage of change in ECV originating from PV and pre-
dialysis IFV confirmed the findings of Koomans et al [39] and
indicate that the risk for hypovolemia during ultrafiltration is
dependent on the initial state of hydration.
The repletion of PY after ultrafiltration in the patients in
dry-weight was not completed on day 4, approximately 20 hours
after treatment. However, dialysis patients with an interdialytic
weight gain of more than 0.5 to 1 kg are never in steady—state
regarding body fluid volumes. The present study indicated that
hemodialysis patients were fluctuating between a pre-dialysis
state of fluid retention with increased IFY, reduced II, and
increased III, — III, and a dry-weight state with normal IFV,
normal to reduced BY and still higher III, — III. The changes in
the transcapillary colloid osmotic pressures in the pre-dialysis
and in the dry-weight state tended to limit the increase in IFV
and to preserve BY. Activation of these edema—preventing and
plasma volume preserving factors was not sufficient to normal-
ize the transcapillary fluid balance (BY/IFV) either in pre-
dialysis nor in a dry-weight state.
Reprint requests to Per Fauchald, M.D., Medical Department B,
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